Literature DB >> 21881570

Abnormal glucocorticoid receptor mRNA and protein isoform expression in the prefrontal cortex in psychiatric illness.

Duncan Sinclair1, Shan Yuan Tsai, Heng Giap Woon, Cynthia Shannon Weickert.   

Abstract

Stress has been implicated in the onset and illness course of schizophrenia and bipolar disorder. The effects of stress in these disorders may be mediated by abnormalities of the hypothalamic-pituitary-adrenal axis, and its corticosteroid receptors. We investigated mRNA expression of the glucocorticoid receptor (GR) and mineralocorticoid receptor (MR), and protein expression of multiple GRα isoforms, in the prefrontal cortex of 37 schizophrenia cases and 37 matched controls. Quantitative real-time PCR, western blotting, and luciferase assays were employed. In multiple regression analysis, schizophrenia diagnosis was a significant predictor of total GR mRNA expression (p<0.05), which was decreased (11.4%) in schizophrenia cases relative to controls. No significant effect of diagnosis on MR mRNA was detected. At the protein level, no significant predictors of total GRα protein or the full-length GRα isoform were identified. However, schizophrenia diagnosis was a strong predictor (p<0.0005) of the abundance of a truncated ≈ 50 kDa GRα protein isoform, putative GRα-D1, which was increased in schizophrenia cases (80.4%) relative to controls. This finding was replicated in a second cohort of 35 schizophrenia cases, 34 bipolar disorder cases, and 35 controls, in which both schizophrenia and bipolar disorder diagnoses were significant predictors of putative GRα-D1 abundance (p<0.05 and p=0.005, respectively). Full-length GRα was increased in bipolar disorder relative to schizophrenia cases. Luciferase assays demonstrated that the GRα-D1 isoform can activate transcription at glucocorticoid response elements. These findings confirm total GR mRNA reductions in schizophrenia and provide the first evidence of GR protein isoform abnormalities in schizophrenia and bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881570      PMCID: PMC3230493          DOI: 10.1038/npp.2011.160

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  54 in total

1.  Obstetric complications and schizophrenia: historical and meta-analytic review.

Authors:  Mary Cannon; Peter B Jones; Robin M Murray
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

2.  Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.

Authors:  M J Webster; M B Knable; J O'Grady; J Orthmann; C S Weickert
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

3.  Identification of a biological signature for schizophrenia in serum.

Authors:  E Schwarz; P C Guest; H Rahmoune; L W Harris; L Wang; F M Leweke; M Rothermundt; B Bogerts; D Koethe; L Kranaster; P Ohrmann; T Suslow; G McAllister; M Spain; A Barnes; N J M van Beveren; S Baron-Cohen; J Steiner; F E Torrey; R H Yolken; S Bahn
Journal:  Mol Psychiatry       Date:  2011-04-12       Impact factor: 15.992

4.  The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.

Authors:  H Y Meltzer; M A Lee; K Jayathilake
Journal:  Neuropsychopharmacology       Date:  2001-03       Impact factor: 7.853

5.  Dexamethasone suppression test and suicide attempts in schizophrenic patients.

Authors:  M Płocka-Lewandowska; A Araszkiewicz; J K Rybakowski
Journal:  Eur Psychiatry       Date:  2001-11       Impact factor: 5.361

6.  Different neuroendocrine profiles of remitted and nonremitted schizophrenic patients.

Authors:  Kemal Yazici; Aylin Ertekin Yazici; Bilgen Taneli
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-04       Impact factor: 5.067

7.  Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium.

Authors:  M B Knable; E F Torrey; M J Webster; J J Bartko
Journal:  Brain Res Bull       Date:  2001-07-15       Impact factor: 4.077

8.  Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing.

Authors:  C Rivers; A Levy; J Hancock; S Lightman; M Norman
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

9.  Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study.

Authors:  R Poulton; A Caspi; T E Moffitt; M Cannon; R Murray; H Harrington
Journal:  Arch Gen Psychiatry       Date:  2000-11

10.  Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues.

Authors:  Laura Pujols; Joaquim Mullol; Jordi Roca-Ferrer; Alfons Torrego; Antoni Xaubet; John A Cidlowski; César Picado
Journal:  Am J Physiol Cell Physiol       Date:  2002-10       Impact factor: 4.249

View more
  24 in total

Review 1.  DNA modifications and neurological disorders.

Authors:  Yi-Lan Weng; Ran An; Jaehoon Shin; Hongjun Song; Guo-li Ming
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 2.  Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice.

Authors:  Gloria Laryea; Lisa Muglia; Melinda Arnett; Louis J Muglia
Journal:  Front Neuroendocrinol       Date:  2014-09-27       Impact factor: 8.606

3.  Glucocorticoid receptor alpha translational isoforms as mediators of early adversities and negative emotional states.

Authors:  Miroslav Adzic; Emilija Glavonic; Milica J Nesic; Minja Milosavljevic; Marina Mihaljevic; Zorica Petrovic; Zorana Pavlovic; Zeljka Brkic; Ester Francija; Ivan Soldatovic; Milos Mitic; Jelena Radulovic; Nadja P Maric
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-12-21       Impact factor: 5.067

4.  Glucocorticoid receptor isoform-specific regulation of development, circadian rhythm, and inflammation in mice.

Authors:  Robert H Oakley; Sivapriya Ramamoorthy; Julie F Foley; Jonathan T Busada; Nick Z Lu; John A Cidlowski
Journal:  FASEB J       Date:  2018-04-19       Impact factor: 5.191

5.  Neuropathological changes in the nucleus basalis in schizophrenia.

Authors:  M R Williams; R Marsh; C D Macdonald; J Jain; R K B Pearce; S R Hirsch; O Ansorge; S M Gentleman; M Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-12-11       Impact factor: 5.270

6.  DNA-methylation gene network dysregulation in peripheral blood lymphocytes of schizophrenia patients.

Authors:  J Auta; R C Smith; E Dong; P Tueting; H Sershen; S Boules; A Lajtha; J Davis; A Guidotti
Journal:  Schizophr Res       Date:  2013-08-12       Impact factor: 4.939

Review 7.  The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease.

Authors:  Robert H Oakley; John A Cidlowski
Journal:  J Allergy Clin Immunol       Date:  2013-09-29       Impact factor: 10.793

Review 8.  Toward the identification of peripheral epigenetic biomarkers of schizophrenia.

Authors:  A Guidotti; J Auta; J M Davis; E Dong; D P Gavin; D R Grayson; R P Sharma; R C Smith; P Tueting; A Zhubi
Journal:  J Neurogenet       Date:  2014-04-22       Impact factor: 1.250

9.  Nuclear Receptors and Neuroinflammation in Schizophrenia.

Authors:  Shan-Yuan Tsai; Vibeke S Catts; Janice M Fullerton; Susan M Corley; Stuart G Fillman; Cynthia Shannon Weickert
Journal:  Mol Neuropsychiatry       Date:  2018-01-16

10.  mRNA and microRNA Profiles in the Amygdala Are Relevant to Susceptibility and Resilience to Psychological Stress Induced in Mice.

Authors:  Jinyan Sun; Yanjun Lu; Jiuyong Yang; Zhenhua Song; Wei Lu; Jin-Hui Wang
Journal:  J Mol Neurosci       Date:  2020-05-12       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.